India, March 18 -- Stem cell therapies using induced pluripotent stem cells have received conditional approval in Japan for ...

Longeveron Inc., a biotechnology company focused on regenerative medicine, has licensed a US patent from the University of Miami aimed at developing cardiomyogenic precursor cells from pluripotent ...

An innovative stem cell therapy approved for severe heart failure has been cleared for use in Japan. Here is why it matters ...

A woman with a failing heart has been kept alive with the help of a new "breakthrough" stem-cell technology, scientists report. The 46-year-old woman had experienced a heart attack in 2016 and ...

TORONTO, Oct. 13, 2025 /PRNewswire/ -- Visionary Holdings Inc. ("GV" or the "Company"), a technology-driven multinational enterprise listed on Nasdaq (Nasdaq: GV), today announced that its wholly ...

NeuroScientific Biopharmaceuticals has begun transferring the production of stem cells for its StemSmart therapy to Q-Gen in Brisbane, ahead of Crohn’s disease clinical trials.

MIAMI, July 21, 2025 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening, rare pediatric ...

Leading the commercialization of space-age cellular science for personal care products, Naples Soap Company set to the launch nationally a new personal care product line utilizing NASA’s 3D biometric ...

Japan has approved two stem cell-based therapies for treating Parkinson's disease and heart failure in a world first, through ...